Godavari Biorefineries reported a consolidated net loss of Rs 15.24 crore for the September 2026 quarter, narrowing from the previous quarter's Rs 19.32 crore loss. Half-year losses hit Rs 34.56 crore, partially impacted by a Rs 26.66 crore exceptional expense related to sugarcane harvesting charges. While the sugar and cogeneration segments faced operating losses, the bio-based chemicals and distillery divisions remained profitable during the period.
Godavari Biorefineries Q2 Net Loss Hits Rs 15.24 Crore
Consolidated Net Loss: Rs 15.24 crore for Q2; Exceptional H1 item: Rs 26.66 crore.
Reader Takeaway: Strong performance in bio-based chemicals offset by seasonal sugar segment losses and one-time harvesting charges.
What just happened
Godavari Biorefineries released its financial results for the quarter and half-year ended September 30, 2026. The company reported a consolidated net loss of Rs 15.24 crore for the second quarter, an improvement compared to the Rs 19.32 crore loss recorded in the preceding quarter. For the half-year period, the total consolidated net loss stood at Rs 34.56 crore.
Why this matters
The company’s bottom line was significantly impacted by an exceptional expense of Rs 26.66 crore. Management disclosed that this charge relates to additional harvesting fees paid to contractors for the 2023-2024 sugar season to maintain operational competitiveness. This one-time hit influenced the overall H1 performance.
Segment Performance
Performance across segments was mixed:
- Bio-based Chemicals: Remained a key contributor with an operating profit of Rs 18.77 crore.
- Distillery: Contributed an operating profit of Rs 4.53 crore.
- Sugar: Reported an operating loss of Rs 15.31 crore.
- Cogeneration: Reported an operating loss of Rs 9.78 crore.
Context Metrics
Revenue from operations for the quarter was Rs 549.24 crore, slightly lower than the Rs 557.88 crore recorded in the June 2026 quarter. Total revenue for the half-year reached Rs 1,107.12 crore.
What to track next
Management emphasized that the business is highly seasonal. Investors should monitor how the upcoming cycles for the sugar and cogeneration units impact future cash flows and whether the company can sustain profitability in the bio-based chemicals segment throughout the full fiscal year.
